{"id":"https://openalex.org/W3210104300","doi":"https://doi.org/10.1097/coh.0000000000000709","title":"Doravirine: its role in HIV treatment","display_name":"Doravirine: its role in HIV treatment","publication_year":2021,"publication_date":"2021-11-03","ids":{"openalex":"https://openalex.org/W3210104300","doi":"https://doi.org/10.1097/coh.0000000000000709","mag":"3210104300","pmid":"https://pubmed.ncbi.nlm.nih.gov/34740228"},"language":"en","primary_location":{"id":"doi:10.1097/coh.0000000000000709","doi":"https://doi.org/10.1097/coh.0000000000000709","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coh.0000000000000709","pdf_url":null,"source":{"id":"https://openalex.org/S106953758","display_name":"Current Opinion in HIV and AIDS","issn_l":"1746-630X","issn":["1746-630X","1746-6318"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in HIV and AIDS","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000759820","display_name":"Alexander J. Stockdale","orcid":"https://orcid.org/0000-0002-5828-3328","observed_orcids":["https://orcid.org/0000-0002-5828-3328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander J. Stockdale","raw_affiliation_strings":["Institute of Infection, Veterinary and Ecological Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Infection, Veterinary and Ecological Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Saye Khoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Saye Khoo","raw_affiliation_strings":["Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I146655781"],"apc_list":null,"apc_paid":null,"fwci":0.5104,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.51829268,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"17","issue":"1","first_page":"4","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doravirine","display_name":"doravirine","score":1.0},{"id":"https://openalex.org/keywords/hiv-1-treatment","display_name":"HIV-1 treatment","score":0.7870000004768372},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9509999752044678},{"id":"https://openalex.org/keywords/darunavir-ritonavir","display_name":"darunavir/ritonavir","score":0.9789999723434448},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5920000076293945},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.7730000019073486},{"id":"https://openalex.org/keywords/neuropsychiatric-side-effects","display_name":"neuropsychiatric adverse effects","score":0.7540000081062317},{"id":"https://openalex.org/keywords/lipid-changes","display_name":"lipid changes","score":0.8050000071525574},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.843999981880188},{"id":"https://openalex.org/keywords/hepatic-and-renal-impairment","display_name":"renal and hepatic impairment","score":0.8769999742507935},{"id":"https://openalex.org/keywords/primary-drug-resistance","display_name":"primary drug resistance","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.654699981212616},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6014000177383423},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.5636000037193298},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5085999965667725},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.48660001158714294},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4212999939918518},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.37400001287460327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.353300005197525},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3479999899864197},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.3456000089645386},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.3361999988555908},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.31520000100135803},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.30250000953674316},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29089999198913574},{"id":"https://openalex.org/C2909254382","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"ANTIRETROVIRAL AGENTS","level":5,"score":0.289900004863739},{"id":"https://openalex.org/C3019165603","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral treatment","level":5,"score":0.2831000089645386},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2784999907016754},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26919999718666077},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.26179999113082886}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/coh.0000000000000709","doi":"https://doi.org/10.1097/coh.0000000000000709","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coh.0000000000000709","pdf_url":null,"source":{"id":"https://openalex.org/S106953758","display_name":"Current Opinion in HIV and AIDS","issn_l":"1746-630X","issn":["1746-630X","1746-6318"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in HIV and AIDS","raw_type":"journal-article"},{"id":"pmid:34740228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34740228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in HIV and AIDS","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W2043497020","https://openalex.org/W2149148148","https://openalex.org/W2151768713","https://openalex.org/W2256825639","https://openalex.org/W2327696366","https://openalex.org/W2330399120","https://openalex.org/W2565343787","https://openalex.org/W2601464367","https://openalex.org/W2742578179","https://openalex.org/W2773554166","https://openalex.org/W2792742326","https://openalex.org/W2800224917","https://openalex.org/W2808028879","https://openalex.org/W2889157553","https://openalex.org/W2905212625","https://openalex.org/W2917684789","https://openalex.org/W2938502016","https://openalex.org/W2945985905","https://openalex.org/W2965906673","https://openalex.org/W2966066929","https://openalex.org/W2969281750","https://openalex.org/W2976245304","https://openalex.org/W2979917028","https://openalex.org/W2986321983","https://openalex.org/W3002151074","https://openalex.org/W3004709621","https://openalex.org/W3008047682","https://openalex.org/W3037908551","https://openalex.org/W3071645158","https://openalex.org/W3083034332","https://openalex.org/W3092046481","https://openalex.org/W3094950797","https://openalex.org/W3112670934","https://openalex.org/W3119144888","https://openalex.org/W3156341605","https://openalex.org/W3158467183","https://openalex.org/W3159729328","https://openalex.org/W3161186130","https://openalex.org/W3196315792"],"related_works":["https://openalex.org/W3006945212","https://openalex.org/W3009824331","https://openalex.org/W2803560531","https://openalex.org/W2965906673","https://openalex.org/W3034880455","https://openalex.org/W2792742326","https://openalex.org/W3084799445","https://openalex.org/W2995070850","https://openalex.org/W4380290416","https://openalex.org/W2256825639"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"We":[3],"reviewed":[4],"evidence":[5,173],"concerning":[6],"the":[7,34,112,175,182],"novel":[8],"nonnucleoside":[9],"reverse":[10],"transcriptase":[11],"inhibitor":[12],"doravirine,":[13],"aiming":[14],"to":[15,25,73,80,92,106,135,190],"identify":[16],"situations":[17],"where":[18],"it":[19],"may":[20,128,139],"be":[21,129,140],"selected":[22],"in":[23,38,111,131,142,164,181],"preference":[24],"integrase":[26,96,170],"inhibitors.":[27],"RECENT":[28],"FINDINGS:":[29],"Doravirine":[30,61,100,138,156],"is":[31,62,125,157],"licenced":[32],"for":[33,152],"treatment":[35,178],"of":[36,68,88,114,177,184],"HIV-1":[37],"North":[39],"America":[40],"and":[41,54,75,120,127,147,161,172],"Europe.":[42],"In":[43],"two":[44],"multicentre":[45],"randomized":[46],"controlled":[47],"trials,":[48],"noninferiority":[49],"with":[50,64,95,108,169,179],"comparator":[51],"drugs":[52],"efavirenz":[53],"darunavir/ritonavir":[55],"was":[56,98],"observed":[57],"at":[58],"96":[59,83],"weeks.":[60,84],"associated":[63],"a":[65,102,149,158],"lower":[66,86],"incidence":[67,87],"neuropsychiatric":[69],"side":[70],"effects":[71],"relative":[72,79,91,134],"efavirenz,":[74],"favourable":[76],"lipid":[77],"changes":[78],"darunavir":[81],"over":[82],"A":[85],"weight":[89],"gain,":[90],"indirect":[93],"comparisons":[94],"inhibitors,":[97,171],"observed.":[99],"has":[101,148],"high":[103],"genetic":[104],"barrier":[105],"resistance":[107,124],"retained":[109],"activity":[110],"presence":[113,183],"single":[115],"NNRTI":[116,186],"mutations":[117],"K103N,":[118],"Y181C":[119],"G190A.":[121],"Primary":[122],"drug":[123],"infrequent":[126],"higher":[130],"South":[132],"Africa":[133],"European":[136],"populations.":[137],"used":[141],"renal":[143],"or":[144],"hepatic":[145],"impairment":[146],"low":[150],"potential":[151],"drug-drug":[153],"interactions.":[154],"SUMMARY:":[155],"well":[159],"tolerated":[160],"effective":[162],"agent":[163],"ART-naive":[165],"patients.":[166],"Direct":[167],"comparison":[168],"on":[174],"outcomes":[176],"doravirine":[180,199],"prior":[185],"experience":[187],"are":[188],"required":[189],"better":[191],"elucidate":[192],"which":[193],"patients":[194],"will":[195],"benefit":[196],"most":[197],"from":[198],"therapy.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-11-08T00:00:00"}